Top Markets
Coin of the day
PharmaSGP Holding SE PharmaSGP Holding SE

PharmaSGP Holding SE

PSG
주식 순위 #14729
Founded in 2012 and based in Gräfelfing, Germany, PharmaSGP Holding SE... Founded in 2012 and based in Gräfelfing, Germany, PharmaSGP Holding SE specializes in the production of over-the-counter (OTC) pharmaceuticals and diverse healthcare goods. The company offers an extensive portfolio of products addressing various health concerns. This includes Baldriparan for sleep disturbances; pain relief solutions like Spalt, Formigran, and Kamol massage cream; RubaXX, specifically designed for rheumatic pain in bones, tendons, and muscles; and Restaxil, which targets nerve pain in the neck and back. Furthermore, their offerings encompass Fulminan, a beauty beverage for areas such as the eyes, buttocks, and thighs; DESEO drops for sexual weakness; Neradin, a medication for sexual dysfunction; and TAUMEA, aimed at managing vertigo. PharmaSGP also develops treatments for chronic conditions, including persistent pain and other age-associated ailments. Its products reach consumers via pharmacies and wholesalers, and are exported to several European nations, including Austria, Italy, Belgium, Spain, and France.
주가
$34.40
마지막 동기화: 2025-08-11
시가총액
$396.01M
변동 (1일)
1.83%
변동 (1년)
0.00%
국가
DE
거래 PharmaSGP Holding SE (PSG)

카테고리

B의 시가 총액을 가진 PSG의 가격
PharmaSGP Holding SE PharmaSGP Holding SE
PSG
$34.40
의 시가총액 PharmaSGP Holding SE(PSG)
시가총액: $396.01M
September 2026 기준으로 PharmaSGP Holding SE의 시가총액은 $396.01M입니다. 이는 당사 데이터에 따르면 PharmaSGP Holding SE이 세계에서 14729th번째로 가치 있는 기업임을 의미합니다. 시가총액은 상장된 회사의 발행 주식 총 시장 가치를 의미하며, 일반적으로 회사의 가치를 측정하는 데 사용됩니다.
2011부터 2026까지 PharmaSGP Holding SE의 시가총액 기록
PSG 가장 인기있는 상위 5 가지 stocks과 비교하여
PSG의 가격 자산 b b의 시장 결과
PharmaSGP Holding SE PharmaSGP Holding SE
$462,697 $396.01M
$5.327T +1,345,009.15%
PharmaSGP Holding SE PharmaSGP Holding SE
$403,464 $396.01M
$4.645T +1,172,810.86%
PharmaSGP Holding SE PharmaSGP Holding SE
$353,551 $396.01M
$4.070T +1,027,710.47%
PharmaSGP Holding SE PharmaSGP Holding SE
$328,737 $396.01M
$3.785T +955,571.34%
PharmaSGP Holding SE PharmaSGP Holding SE
$242,356 $396.01M
$2.790T +704,453.82%